| Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic … SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1789-1858, 2018 | 9993 | 2018 |
| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1736-1788, 2018 | 7755 | 2018 |
| Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 MG Griswold, N Fullman, C Hawley, N Arian, SRM Zimsen, HD Tymeson, ... The Lancet 392 (10152), 1015-1035, 2018 | 3503 | 2018 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 2570 | 2018 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 1065 | 2018 |
| Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global … N Fullman, J Yearwood, SM Abay, C Abbafati, F Abd-Allah, J Abdela, ... The Lancet 391 (10136), 2236-2271, 2018 | 860 | 2018 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic … GBD Collaborators University of Leicester, 2018 | 859 | 2018 |
| Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic … R Lozano, N Fullman, D Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 2091-2138, 2018 | 536 | 2018 |
| Assessment of Self-medication practices among medical, pharmacy, health science students in Gondar University, Ethiopia SM Abay, W Amelo Journal of Young Pharmacists 2 (3), 306-310, 2010 | 474 | 2010 |
| Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 CJL Murray, CSKH Callender, XR Kulikoff, V Srinivasan, D Abate, ... The Lancet 392 (10159), 1995-2051, 2018 | 331 | 2018 |
| Acute and Subacute Toxicity of Methanol Extract of Syzygium guineense Leaves on the Histology of the Liver and Kidney and Biochemical Compositions of Blood … M Loha, A Mulu, SM Abay, W Ergete, B Geleta Evidence‐Based Complementary and Alternative Medicine 2019 (1), 5702159, 2019 | 128 | 2019 |
| Ethnomedicinal survey of folk drugs used in Bahirdar Zuria district, Northwestern Ethiopia M Ragunathan, SM Abay CSIR, 2009 | 96 | 2009 |
| The effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: a systematic review and meta-analysis SM Abay, K Deribe, AA Reda, S Biadgilign, D Datiko, T Assefa, M Todd, ... Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2015 | 86 | 2015 |
| GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... Lancet 392 (10159), 1859-1922, 2018 | 76 | 2018 |
| Plasmodium transmission blocking activities of Vernonia amygdalina extracts and isolated compounds SM Abay, L Lucantoni, N Dahiya, G Dori, EG Dembo, F Esposito, G Lupidi, ... Malaria Journal 14, 1-19, 2015 | 75 | 2015 |
| Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date YA Ebstie, SM Abay, WT Tadesse, DA Ejigu Drug design, development and therapy, 2387-2399, 2016 | 72 | 2016 |
| Molecular and immunological diagnostic techniques of medical viruses DH Reta, TS Tessema, AS Ashenef, AF Desta, WL Labisso, ST Gizaw, ... International Journal of Microbiology 2020 (1), 8832728, 2020 | 64 | 2020 |
| Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity S D'Alessandro, Y Corbett, DP Ilboudo, P Misiano, N Dahiya, SM Abay, ... Antimicrobial agents and chemotherapy 59 (9), 5135-5144, 2015 | 62 | 2015 |
| Poly-Electrophilic Sesquiterpene Lactones from Vernonia amygdalina: New Members and Differences in Their Mechanism of Thiol Trapping and in Bioactivity A Sinisi, E Millán, SM Abay, A Habluetzel, G Appendino, E Muñoz, ... Journal of Natural Products 78 (7), 1618-1623, 2015 | 58 | 2015 |
| ME, Accrombessi, MMK,… Murray, CJL (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 … SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1789-1858, 0 | 58 | |
